Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Oncology

Symptoms, Biology, and Your Diagnosis

At a Glance

Adult T-cell leukemia/lymphoma (ATLL) is a rare blood cancer driven by the HTLV-1 virus. Diagnosis relies on identifying specific markers like 'flower cells' in the blood. Hypercalcemia (high calcium) is a severe, common complication of ATLL that requires immediate emergency medical attention.

Understanding the biological blueprint of Adult T-cell leukemia/lymphoma (ATLL) can help you make sense of the wide range of symptoms you may be experiencing. Because ATLL can look like many other conditions, a definitive diagnosis relies on specific markers in your blood and tissues.

The Biological “Drivers” of ATLL

ATLL is not caused by a simple infection; it is the result of the HTLV-1 virus rewriting the instructions inside your T-cells over many years [1]. Two specific viral genes act as the primary drivers:

  • The TAX Gene: This gene acts like an “accelerator pedal.” It turns on a biological pathway that tells the T-cell to keep growing and dividing long after it should have naturally stopped [2][3].
  • The HBZ Gene: While Tax starts the process, HBZ keeps it going. It helps the cancer cells survive, migrate to other organs, and hide from your immune system [4][5].
  • Signaling Changes: Together, these genes hijack the system T-cells normally use to identify threats, turning it into a permanent “on” signal for cancer growth [6][3].

Common and Overlooked Symptoms

ATLL is known for its “clinical variety,” meaning it can affect different parts of the body in different ways [7].

  • Skin Manifestations: Up to half of patients develop skin issues [8]. These can range from small red patches or raised plaques to large tumors. Because these look like common rashes or other skin cancers (like Mycosis Fungoides), they are often misdiagnosed early on [9].
  • Lytic Bone Lesions: These are “punched-out” areas in the bone visible on X-rays or CT scans, caused by cancer cells breaking down the bone [10].
  • Lymph Node Swelling: Rubbery, painless lumps in the neck, armpits, or groin are common as the T-cells accumulate in the lymph nodes [7].
  • Hypercalcemia (High Blood Calcium): This is a hallmark of aggressive ATLL, occurring when bone breakdown releases calcium into the blood [10][11].

EMERGENCY WARNING: Hypercalcemia
Severely high calcium levels are a life-threatening medical emergency. If you experience extreme thirst, frequent urination, severe nausea, profound muscle weakness, or confusion, seek immediate emergency medical care. This is a leading cause of early, severe complications in ATLL.

Completeness Checklist: What Your Reports Should Show

To confirm ATLL, your doctors must look for several specific pieces of evidence. Check your pathology and lab reports for these “must-have” items:

  • [ ] HTLV-1 Serology: Positive test for HTLV-1 antibodies [12].
  • [ ] Flower Cells: The presence of unique, cloverleaf-shaped T-cells on a blood smear [13].
  • [ ] Immunophenotype: A “profile” of the cells. You will see markers like CD4+ and CD25+—these are simply protein tags on the outside of your cells that help doctors identify exactly what type of T-cell has become cancerous [1][14].
  • [ ] Lactate Dehydrogenase (LDH): Often elevated, indicating how active the cancer is [15].
  • [ ] Soluble IL-2 Receptor (sIL-2R): A high level of this protein helps doctors understand the “burden” of the disease in your body [16].
  • [ ] Calcium Levels: Checked routinely to monitor for hypercalcemia [10].

Decoding Technical Terms

Term Plain-Language Definition
Proviral Load (PVL) The amount of HTLV-1 virus integrated into your blood cells [17].
Epidermotropism When T-cells move into the top layer of the skin, a common finding in skin biopsies [9].
Lytic Lesion A site of bone destruction or a “hole” in the bone caused by cancer [10].
Flower Cell A T-cell with a nucleus shaped like petals; a visual “smoking gun” for ATLL [13].
Cytopenia Low levels of healthy blood cells (like red cells or platelets) caused by the cancer [18].

Potential Confusion: What Else Could It Be?

Because ATLL is rare and has varied symptoms, it is frequently confused with other conditions:

  • Mycosis Fungoides (MF) / Sézary Syndrome: Other T-cell cancers that primarily affect the skin [9].
  • Peripheral T-cell Lymphoma (PTCL): A broad group of T-cell cancers that don’t involve the HTLV-1 virus [19].
  • Severe Infections: Such as Cytomegalovirus (CMV), which can cause fever and lymph node swelling [20].
  • Hyperparathyroidism: A non-cancerous condition that also causes high calcium and bone issues [11].

Common questions in this guide

What causes Adult T-cell leukemia/lymphoma (ATLL)?
ATLL is caused by the HTLV-1 virus, which alters the instructions inside your T-cells over many years. Specific viral genes hijack the cells, causing them to keep growing and dividing when they normally should have stopped.
What are flower cells on an ATLL pathology report?
Flower cells are uniquely shaped T-cells that have a nucleus resembling a cloverleaf or flower petals under a microscope. They are considered a visual hallmark for diagnosing ATLL in blood smears.
Why is my calcium level tested if I have ATLL?
ATLL can cause cancer cells to break down bone tissue, which releases large amounts of calcium into your blood. Severely high calcium, called hypercalcemia, is a life-threatening complication that requires immediate emergency medical care.
What does proviral load mean on my lab report?
Proviral load refers to the amount of the HTLV-1 virus that has integrated into your blood cells. Your doctor monitors this number to understand the extent of the viral infection driving the cancer.
Why does ATLL cause skin rashes and tumors?
Because T-cells can migrate to the skin, up to half of ATLL patients develop skin issues. These can range from small red patches and raised plaques to larger skin tumors, which are sometimes misdiagnosed as standard rashes or other skin conditions early on.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was my exact HTLV-1 proviral load at the time of diagnosis?
  2. 2.Does my pathology report show 'flower cells' or other specific shapes in my white blood cells?
  3. 3.Can you walk me through my calcium and LDH levels and what they indicate about my disease?
  4. 4.How was my condition differentiated from similar-looking T-cell lymphomas like Mycosis Fungoides?
  5. 5.What is my sIL-2R level, and how will we use that number to monitor my response to treatment?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    HTLV-1 bZIP factor: the key viral gene for pathogenesis.

    Matsuoka M, Mesnard JM

    Retrovirology 2020; (17(1)):2 doi:10.1186/s12977-020-0511-0.

    PMID: 31915026
  2. 2

    The E3/E4 ubiquitin conjugation factor UBE4B interacts with and ubiquitinates the HTLV-1 Tax oncoprotein to promote NF-κB activation.

    Mohanty S, Han T, Choi YB, et al.

    PLoS pathogens 2020; (16(12)):e1008504 doi:10.1371/journal.ppat.1008504.

    PMID: 33362245
  3. 3

    NF-κB and MicroRNA Deregulation Mediated by HTLV-1 Tax and HBZ.

    Fochi S, Ciminale V, Trabetti E, et al.

    Pathogens (Basel, Switzerland) 2019; (8(4)) doi:10.3390/pathogens8040290.

    PMID: 31835460
  4. 4

    HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4(+) T cells.

    Kawatsuki A, Yasunaga JI, Mitobe Y, et al.

    Oncogene 2016; (35(34)):4509-17 doi:10.1038/onc.2015.510.

    PMID: 26804169
  5. 5

    HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).

    Yasuma K, Yasunaga J, Takemoto K, et al.

    PLoS pathogens 2016; (12(1)):e1005372 doi:10.1371/journal.ppat.1005372.

    PMID: 26735971
  6. 6

    Genetic Alterations in Adult T-Cell Leukemia/Lymphoma: Novel Discoveries with Clinical and Biological Significance.

    Sakihama S, Karube K

    Cancers 2022; (14(10)) doi:10.3390/cancers14102394.

    PMID: 35625999
  7. 7

    Human T-cell Lymphotropic Virus Type 1 (HTLV-1)-Associated Adult T-cell Leukemia/Lymphoma in a Patient Previously Treated for Strongyloidiasis.

    Basharat A, Anwar MY, Sulh M, et al.

    Cureus 2023; (15(10)):e47283 doi:10.7759/cureus.47283.

    PMID: 38021878
  8. 8

    Cutaneous manifestations of adult T-cell leukemia/lymphoma.

    Miyashiro D, Sanches JA

    Seminars in diagnostic pathology 2020; (37(2)):81-91 doi:10.1053/j.semdp.2019.07.010.

    PMID: 31387753
  9. 9

    Primary cutaneous smoldering adult T-cell leukemia/ lymphoma.

    Gittler J, Martires K, Terushkin V, et al.

    Dermatology online journal 2016; (22(12)).

    PMID: 28329538
  10. 10

    HTLV-1-Associated Lymphoma Presented as Massive Lymphadenopathy.

    Chen PT, Onukogu D, Gotlieb G, et al.

    Journal of investigative medicine high impact case reports 2021; (9()):23247096211013235 doi:10.1177/23247096211013235.

    PMID: 33969717
  11. 11

    Hypercalcemia as the Initial Presentation of Acute T-cell Leukemia/Lymphoma.

    Ramachandran V

    Cureus 2022; (14(3)):e23705 doi:10.7759/cureus.23705.

    PMID: 35505762
  12. 12

    Epidemiology of adult T-cell leukemia/lymphoma (ATL) in people living with HTLV-1: A 30-year study in Peru.

    Garrido-Pinzás G, Valenzuela B, González-Lagos E, et al.

    PLoS neglected tropical diseases 2026; (20(2)):e0014010 doi:10.1371/journal.pntd.0014010.

    PMID: 41729993
  13. 13

    Hypercalcemia and Flower Cells on Peripheral Smear Revealing Human T-lymphotropic Virus Type 1 (HTLV-1)-Associated Adult T-cell Leukemia/Lymphoma.

    Williams JM, Clark B, Verdecia J, An J

    Cureus 2026; (18(2)):e103225 doi:10.7759/cureus.103225.

    PMID: 41822663
  14. 14

    Risk stratification of adult T-cell leukemia/lymphoma using immunophenotyping.

    Kagdi HH, Demontis MA, Fields PA, et al.

    Cancer medicine 2017; (6(1)):298-309 doi:10.1002/cam4.928.

    PMID: 28035765
  15. 15

    Adult T-cell Leukemia/Lymphoma as a Methotrexate-associated Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis.

    Takajo I, Umekita K, Ikei Y, et al.

    Internal medicine (Tokyo, Japan) 2018; (57(14)):2071-2075 doi:10.2169/internalmedicine.0308-17.

    PMID: 29491299
  16. 16

    Prognostic impact of soluble interleukin-2 receptor level profiling in smoldering type adult T-cell leukemia-lymphoma.

    Kubota A, Nakano N, Tokunaga M, et al.

    Hematological oncology 2019; (37(2)):223-225 doi:10.1002/hon.2574.

    PMID: 30656718
  17. 17

    Risk Factors for Malignant Progression to Adult-T-Cell Leukemia/Lymphoma in HTLV-1 Carriers: A Systematic Review of Cohort and Case-Control Studies.

    Estrada-Grossmann JM, Alarcón-Braga EA, Salazar-Valdivia FE, et al.

    Clinical lymphoma, myeloma & leukemia 2025; (25(10)):720-729.e2 doi:10.1016/j.clml.2025.04.013.

    PMID: 40393837
  18. 18

    Primary bone adult T cell lymphoma with multiple skeletal lesions and debilitating painful osteolysis: a case report.

    Kato H, Koga M, Kobayashi H, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2021; (32(5)):1013-1017 doi:10.1007/s00198-020-05720-6.

    PMID: 33128574
  19. 19

    Lymphomatous adult T cell leukaemia/lymphoma with anaplastic morphology in a country non-endemic for HTLV: a mimicker of anaplastic large cell lymphoma.

    Li CH, Chang ST, Wu HC, et al.

    Histopathology 2020; (77(4)):678-680 doi:10.1111/his.14173.

    PMID: 32510673
  20. 20

    Severe cytomegalovirus colitis with highly elevated sIL-2R mimicking aggressive transformation of adult T-cell lymphoma.

    Tabata R, Tabata C, Yasumizu R

    Antiviral therapy 2016; (21(7)):641-645 doi:10.3851/IMP3050.

    PMID: 27058178

This page explains ATLL symptoms, biology, and diagnostic terminology for educational purposes only. Always consult your hematologist or oncologist for medical advice and help interpreting your specific lab results.

Get notified when new evidence is published on Adult T-cell leukemia/lymphoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.